MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
52.78%
Quick Ratio
52.78%
Cash Ratio
29.86%
Debt to Asset Ratio
222.33%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Marketable securities
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Embedded derivative liability at...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
41,148
41,028
37,732
8,933
Marketable securities
15,878
58,187
99,200
171,291
Receivable from contracts with collaborators
6,105
9,252
12,227
9,243
Prepaid expenses and other current assets
9,594
16,069
18,485
14,522
Total current assets
72,725
124,536
167,644
203,989
Property and equipment, net
55
59
64
70
Operating lease right-of-use assets
3,658
3,906
4,133
4,354
Other assets
429
398
408
407
Total assets
76,867
128,899
172,249
208,820
Accounts payable
5,951
10,822
5,959
1,116
Accrued research and development expenses
9,680
17,395
21,662
17,736
Current contract liabilities
7,068
8,741
19,987
23,974
Current convertible senior notes
36,145
-
-
-
Warrant liability at fair value
18,291
-
-
-
Embedded derivative liability at fair value
42,938
-
-
-
Accrued expenses and other current liabilities
17,710
19,548
15,827
19,291
Total current liabilities
137,783
56,506
63,435
62,117
Long-term convertible senior notes
0
198,763
198,508
198,257
Operating lease liabilities - long-term
2,958
3,213
3,460
3,700
Long-term contract liabilities
30,155
31,900
29,606
27,079
Total liabilities
170,896
290,382
295,009
291,153
Common stock, 0.0001 par value 700,000,000 shares authorized as of june30, 2026 and december31, 2025 488,846,723 shares issued and outstanding as of june30, 2026, and 233,677,057 shares issued and outstanding as of december31, 2025
50
24
24
24
Additional paid-in capital
1,378,357
1,328,119
1,321,303
1,314,450
Accumulated deficit
-1,468,702
-1,485,602
-1,438,938
-1,391,700
Accumulated other comprehensive loss
-3,734
-4,024
-5,149
-5,107
Total stockholders' deficit
-94,029
-161,483
-122,760
-82,333
Total liabilities and stockholders' deficit
76,867
128,899
172,249
208,820
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$41,148K (56.40%↑ Y/Y)Marketable securities$15,878K (-91.49%↓ Y/Y)Prepaid expenses andother current assets$9,594K (-37.71%↓ Y/Y)Receivable from contractswith collaborators$6,105K (-19.45%↓ Y/Y)Total current assets$72,725K (-69.17%↓ Y/Y)Operating leaseright-of-use assets$3,658K (-19.92%↓ Y/Y)Other assets$429K (12.01%↑ Y/Y)Property and equipment,net$55K (-27.63%↓ Y/Y)Total assets$76,867K (-68.10%↓ Y/Y)Accumulated deficit-$1,468,702K (-9.32%↓ Y/Y)Accumulated othercomprehensive loss-$3,734K (26.61%↑ Y/Y)Total liabilities andstockholders' deficit$76,867K (-68.10%↓ Y/Y)Total stockholders'deficit-$94,029K (-103.94%↓ Y/Y)Additional paid-in capital$1,378,357K (5.83%↑ Y/Y)Common stock, 0.0001par value...$50K (117.39%↑ Y/Y)Total liabilities$170,896K (-40.46%↓ Y/Y)Total currentliabilities$137,783K (157.09%↑ Y/Y)Long-term contractliabilities$30,155K (-4.25%↓ Y/Y)Operating leaseliabilities - long-term$2,958K (-24.81%↓ Y/Y)Embedded derivativeliability at fair value$42,938K Current convertiblesenior notes$36,145K Warrant liability atfair value$18,291K Accrued expenses andother current...$17,710K (40.06%↑ Y/Y)Accrued research anddevelopment expenses$9,680K (-37.95%↓ Y/Y)Current contractliabilities$7,068K (-69.89%↓ Y/Y)Accounts payable$5,951K (217.22%↑ Y/Y)

Gossamer Bio, Inc. (GOSS)

Gossamer Bio, Inc. (GOSS)